Viewing StudyNCT06461949



Ignite Creation Date: 2024-07-17 @ 11:16 AM
Last Modification Date: 2024-10-26 @ 3:32 PM
Study NCT ID: NCT06461949
Status: WITHDRAWN
Last Update Posted: 2024-07-15
First Post: 2024-06-08

Brief Title: Study of Dupilumab 300 mg Every Other Week After Endoscopic Sinus Surgery in Patients With Allergic Fungal Rhinosinusitis AFRS on a Background Therapy With Intranasal Corticosteroid Spray
Sponsor:
Organization: National Institutes of Health Clinical Center CC

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 132
Enrollment Type: ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE3
Observational Models:
Time Perspective List:
Who Masked List: